Pharmaceutical packaging serves as the “first protective barrier” for drug quality, directly affecting storage stability, shelf life, and clinical medication safety. Nifedipine controlled‑release tablets – a commonly used long‑acting antihypertensive agent belonging to the dihydropyridine class of calcium channel blockers – contain unsaturated double bonds in their molecular structure. This makes them susceptible to oxidation, photolysis, and hydrolysis under the influence of light, moisture, and oxygen, potentially leading to loss of active ingredient and increased impurities, thus compromising drug quality. Therefore, appropriate packaging materials and structural design are critical for ensuring stable drug efficacy.

While conventional aluminum‑plastic blister packs are common in the market, Honglin Pharmaceutical focuses on rigorous quality control. Considering the physicochemical properties of nifedipine and findings from relevant stability studies, the company has developed a customized packaging solution for its antihypertensive product Jiu‑Bao‑Ping® nifedipine controlled‑release tablets: a cold‑formed solid pharmaceutical composite sheet made of polyamide/aluminum/PVC, combined with pharmaceutical aluminum foil – i.e., a dual‑aluminum package. This dual‑aluminum packaging features a multi‑layer dense barrier structure, providing comprehensive protection against moisture, light, and oxygen:

• The polyamide layer enhances moisture resistance and mechanical strength, reducing the risk of package damage.
• The aluminum layer offers complete light blocking and high‑efficiency oxygen barrier, preventing light and oxygen ingress.
• The PVC layer further strengthens moisture sealing, maintaining a dry internal environment.

These multiple protective mechanisms work synergistically to suppress degradation of the active ingredient nifedipine, keeping key quality attributes such as drug content and related substances stable. Accelerated stability studies (40 °C ± 2 °C, 75 % ± 5 % relative humidity) and long‑term stability studies (30 °C ± 2 °C, 65 % ± 5 % RH) have demonstrated the excellent performance of this dual‑aluminum packaging. It effectively isolates the product from external influences, ensuring quality stability throughout its shelf life.

With a commitment to selecting high‑grade materials and safeguarding drug efficacy through professionalism, Honglin Pharmaceutical pays close attention to every detail of pharmaceutical packaging. The high‑barrier dual‑aluminum package provides a solid quality foundation for Jiu‑Bao‑Ping® nifedipine controlled‑release tablets, upholding drug stability with expertise and protecting public health with quality dedication.

Important note: This product is a prescription medicine. The information above is for corporate quality‑control knowledge sharing only and does not constitute any medication recommendation or medical advice. Please use the medicine only as prescribed by a physician.